共 50 条
- [5] Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study BREAST JOURNAL, 2019, 25 (02): : 237 - 242
- [10] Dose-dense anthracycline- and taxane-based chemotherapy remains the preferred treatment for selected patients with high-risk early breast cancer LANCET REGIONAL HEALTH-EUROPE, 2025, 49